Health
HIV study set to change international treatment recommendations – Australian Hospital + Healthcare Bulletin
New findings by researchers at the UBC Faculty of Medicine are set to change international treatment recommendations for people with newly diagnosed HIV.
New findings by researchers at the UBC Faculty of Medicine are set to change international treatment recommendations for people with newly diagnosed HIV an update that could affect nearly two million people per year worldwide.
Commissioned by the World Health Organization (WHO) as part of a planned update to its guidelines for HIV antiretroviral treatment (ART), the study found that dolutegravir is the optimal medication for first-line treatment for people newly diagnosed with HIV, a choice that…
Continue Reading
